ARCHIVES

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Beings Accelerated Review Of R01s That just Miss Payline

March 29, 1996

World Conference To Consider Smoking Problem, Research, Action

March 14, 1975

Sarcoma Survivors At Risk Of Blood Clots, Study Finds

May 25, 2007

Duke Retraction May Alter IOM Investigation; Review Panel Membership Announced

November 5, 2010

A “Screw-Up” Worked in MD Anderson’s Favor In Seven-Year Stint as U.S. News & World Report Top-Ranked Cancer Center

July 19, 2013

NCI to Seek Concept Approval For Continuing Group Outreach Program; Five CCOP Proposals Reviewed

July 15, 1983